Prism is a manufacturer and provider of specialist healthcare equipment.

Investment type
  • Management buyout
Exit type
  • Private equity sale
Exit date

December 2018

The Team
LDC Team
Quote mark

LDC have helped to guide a growth journey that has ultimately seen us expand across the UK, ramp up exports and enter new markets segments – all of which means we can bring more of our market leading products to those who need it the most.”

Stuart Meldrum, Chief Executive
Prism Medical

Over the four-year partnership with LDC, Prism launched an average of five new products a year and expanded overseas to new markets including Australia and China. When we exited the business, international sales had grown to the point where they accounted for 10 per cent of turnover.

Doubling revenues

During its four years with LDC, Prism recorded a 54 per cent increase in revenues to £40m.

LDC exited the investment in Prism in December 2018 with a sale to Limerston Capital.

Quote mark

Our partnership with LDC provided the financial firepower and strategic guidance we needed to kickstart an acquisitive growth strategy and the team’s support has been instrumental in helping us to achieve our ambitions.”

Stuart Meldrum, Chief Executive
Prism Medical